Is Aristo Bio-Tech overvalued or undervalued?
As of September 16, 2025, Aristo Bio-Tech is considered very expensive and overvalued, with a PE Ratio of 23.31, despite outperforming the Sensex with a 1-year return of 30.95%.
As of 16 September 2025, the valuation grade for Aristo Bio-Tech has moved from expensive to very expensive. This indicates a significant concern regarding its current market valuation. The company is deemed overvalued based on its key financial ratios, which include a PE Ratio of 23.31, an EV to EBITDA of 12.45, and a PEG Ratio of 5.68. In comparison to its peers, Aristo Bio-Tech's PE Ratio is notably lower than that of P I Industries at 35.02 and Bayer CropSci at 39.94, both categorized as very expensive. However, it is higher than UPL, which is rated attractive with a PE Ratio of 35.19. The company's recent stock performance has outpaced the Sensex, with a 1-year return of 30.95% compared to the Sensex's decline of 0.57%, but this does not mitigate the overvaluation concern. Overall, Aristo Bio-Tech appears to be overvalued in the current market environment.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
